In another study, it was demonstrated that IL-6 upregulates the expression of indoleamine-pyrrole 2,3-dioxygenase (IDO) enzyme via NF-κB activation, thereby enhancing the immunosuppressive function of MDSCs in breast cancer [36]. This evidence concerns the gene IL6 and breast cancer.